CORONA Remedies Limited (NSE:CORONA)
India · Delayed Price · Currency is INR 1,697.00
-4.20 (-0.25%)
At close: May 26, 2026
CORONA Remedies Market Cap
CORONA Remedies has a market cap or net worth of 102.46 billion as of May 27, 2026.
Market Cap
102.46B
Enterprise Value
103.66B
Revenue
14.03B
Ranking
n/a
PE Ratio
55.34
Stock Price
1,697.00
Market Cap Chart
Since December 15, 2025, CORONA Remedies's market cap has increased from 87.97B to 102.46B, an increase of 16.46%. That is a compound annual growth rate of 40.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 102.46B | 20.96% |
| Dec 31, 2025 | 84.70B | -3.72% |
| Dec 15, 2025 | 87.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 219.89B |
| Granules India | 187.53B |
| Jubilant Pharmova | 159.52B |
| Rubicon Research | 155.61B |
| Caplin Point Laboratories | 154.72B |
| Viyash Scientific | 113.76B |
| Procter & Gamble Health | 94.97B |
| Sanofi India | 73.39B |